相关实验视频

Updated: May 20, 2025

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

开发伊塔科纳酸聚合物微粒用于细胞内调节促炎性巨细胞激活

Kaitlyn E Woodworth¹, Zachary S C S Froom¹, Natasha D Osborne²

¹School of Biomedical Engineering, Faculties of Medicine and Engineering, Dalhousie University, Halifax, NS, B3H 4R2, Canada.

Advanced healthcare materials

|April 4, 2025

概括

研究人员开发了伊塔科纳酸微粒 (IA-MPs) 用于针对性免疫系统传递. 这些IA-MP有效地在细胞内输送伊塔科纳酸,调节炎症反应并提供治疗炎症疾病的新策略.

科学领域:

生物医学工程生物医学工程
免疫学免疫学免疫学
药物输送系统药物输送系统

背景情况:

伊塔科纳酸 (IA) 是一种内源代谢物,对先天免疫调节至关重要.
目前使用IA的免疫调节疗法受限于不良的输送和低细胞吸收.
有效的细胞内传递对于IA的治疗活性至关重要.

研究的目的:

开发一种基于微粒的输送系统,用于细胞内输送伊塔科纳酸.
为了创建生物降解的聚微粒加载伊塔可纳酸盐 (IA-MPs).
评估IA-MPs在调节免疫反应中的有效性和安全性.

主要方法:

使用乳液方法制造IA装载的多二甲基伊塔康酸) 微粒 (IA-MPs).
对IA-MP材料特性和伊塔康酸释放动力学的表征.
在实验室中评估IA-MP的细胞化,细胞毒性和对小鼠巨细胞的免疫调节作用.

主要成果:

生产了微米级 (≈1.5μm) 的可生物降解的IA-MPs与受控释放.
通过低细胞毒性巨体通过IA-MPs的有效的细胞酶介导内部化.
确认了IA-MP特定的炎症点的调节和氧化代谢的抑制,与IA的机制一致.

结论:

开发了一种基于伊塔康酸盐的新型聚合物微粒系统,用于增强细胞内输送.
IA-MP显示了针对性免疫调节和炎症疾病治疗的潜力.
该平台为开发其他基于代谢物的微粒药物递送系统提供了基础.

关键词:

生物材料是一种生物材料.免疫代谢的免疫代谢.这是一种炎症炎症炎症炎症.这些微粒是微粒.聚聚是什么意思聚聚是一种

更多相关视频

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

相关概念视频

Inflammatory Response

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...